PharmTech Group

EMA has given a positive recommendation for a change in the gas propellant in Trixeo Aerosphere and Riltrava Aerosphere that will have a 1000-fold reduction in global warming potential compared to the current propellant. #inhalation #EMA hubs.li/Q03yZFRk0

The action from @HHSGov @SecKennedy follows a recommendation from @CDCgov's ACIP, which the Secretary recently repopulated with new members after dismissing all 17 former ones. #influenza #flu #vaccines #thimerosal hubs.li/Q03yQ9qN0

In regard to recent #Tariffs news, @AlstonBirdLLP's Jason Waite, international trade lead, discusses what to watch for, #pharmaceutical cost impacts, and supply chain strategies, including drug shortage risks & pressure on generics amid the reshoring push pharmtech.com/view/tariffs-t…

In this episode of the Ask the Expert video series, Susan J. Schniepp, Regulatory Compliance Associates, and Siegfried Schmitt, PhD, @Parexel, discuss if and when identity testing is necessary to be performed on a final product. #asktheexpert hubs.li/Q03yJLCP0

Speedier implementation of the Post-Approval Change Management Protocol is essential for it to have a positive effect on supply security, says Siegfried Schmitt, PhD, vice president, Technical at Parexel. hubs.li/Q03ytN9z0

Effective PK/PD modeling requires specialized expertise, time, and resources that are not always readily available. #PK/PD modeling #analytics hubs.li/Q03ysQlr0

Even though the next @packexposhow is still more than two months away, plans and attractions are being announced for #PACKEXPO Las Vegas 2025. hubs.li/Q03ym-Ld0

A supplemental new drug application acceptance by @US_FDA adds the United States to China, Japan, and the European Union as areas where @bmsnews's #Sotyktu is now indicated for psoriatic arthritis. hubs.li/Q03ygxkR0

AstraZeneca will build a multi-billion-dollar drug manufacturing center in Virginia that will focus on chronic diseases, as well as facilities in California, Indiana, Maryland, Massachusetts, and Texas. hubs.li/Q03yd6nz0

George Francis Tidmarsh, MD, PhD, founding co-director of Stanford’s Master of Translational Research and Applied Medicine program, has been appointed as the new director of the Center for Drug Evaluation and Research. hubs.li/Q03y53b40

Remain flexible, develop cross-functional capabilities, and ensure their work contributes directly to core pipeline priorities That's the gist from our take on what Sarepta & other #biopharm layoffs mean to industry professionals biopharminternational.com/view/what-sare…

Discover current trends, identify key strategies to accelerate early-phase development, share approaches to speeding up timelines for even the most complex formats, and look into the future of advancements in large-molecule manufacturing. Register now: hubs.li/Q03w5KqP0

Check out our quick, easy-to-digest take on a 6-stage #pharmaceutical #compounding framework you should know about, summarizing an extensive review from industry professionals at, among others, @RooseveltU and @UICPharm pharmtech.com/view/the-6-sta…

Regular contributors Dr. Pluta, Alan Mancini, @RooseveltU's Dr. Thakar & @UICPharm's Dr. Chaiyaperm offer a detailed, ordered process for compounding #pharmaceutical dosage forms in #503A pharmacies, #503B outsourcing, #pharma, and other work environments pharmtech.com/view/dosage-fo…

Discover current trends, identify key strategies to accelerate early-phase development, share approaches to speeding up timelines for even the most complex formats, and look into the future of advancements in large-molecule manufacturing. Register now: hubs.li/Q03w5DqY0

EMA's Executive Steering Group on Shortages and Safety of Medicinal Products has issued recommendations to address vulnerabilities in the supply chain of anti-D immunoglobulins. hubs.li/Q03wKZvY0

Hydrogels, drug-eluting contact lenses, and other implant technologies show real promise for delivery of ocular therapies. hubs.li/Q03vHRV_0